Screener
Relmada Therapeutics, Inc. RLMD Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001213900-26-055059
| Line item | As of / March 31, | As of |
|---|---|---|
| Cash and cash equivalents | $9,776,400 | $3,496,540 |
| Short-term investments | 224,186,743 | 89,509,710 |
| Prepaid expenses | 1,380,151 | 977,721 |
| Total current assets | 235,343,294 | 93,983,971 |
| Other assets | 19,500 | 19,500 |
| Total assets | $235,362,794 | $94,003,471 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is Relmada Therapeutics, Inc.'s total current assets?
- Relmada Therapeutics, Inc. (RLMD) reported total current assets of $235.34M in Q1 2026.
- How has Relmada Therapeutics, Inc.'s total current assets changed year-over-year?
- Relmada Therapeutics, Inc.'s total current assets increased by 750.9% year-over-year, from $27.66M to $235.34M.
- What is the long-term trend for Relmada Therapeutics, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Relmada Therapeutics, Inc.'s total current assets has grown at a -4.5% compound annual growth rate (CAGR), from $118.07M to $93.98M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Relmada Therapeutics, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude